ORGO logo

Organogenesis Holdings (ORGO) Cash From Operations

Annual CFO

$14.21 M
-$16.71 M-54.04%

December 31, 2024

Summary

Performance

1-Year Change

-54.04%

3-Year Change

-77.08%

5-Year Change

+142.38%

15-Year Change

+506.76%

ORGO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.57%
ORGO annual cash flow from operations is higher than 79.57% of companies in Healthcare sector

High & Low

All-time High

$61.98 M
ORGO annual cash flow from operations is currently -77.08% below its historical high of $61.98 million

3-Year Low

$14.21 M
ORGO annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ORGO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ORGO next annual earnings announcement has not yet been scheduled

OtherORGOcash flowmetrics:

Annual CFI

-$10.03 M
ORGO annual cash flow from investing activities is -$10.03 million

Annual CFF

$27.64 M
ORGO annual cash flow from financing activities is $27.64 million

Annual FCF

$4.18 M
ORGO annual free cash flow is $4.18 million

Annual CAPEX

$10.03 M
ORGO annual capital expenditures is $10.03 million

Quarterly CFO

$10.94 M
+$2.24 M+25.78%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-39.06%

5-Year Change

+941.31%

ORGO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.07%
ORGO quarterly cash flow from operations is higher than 82.07% of companies in Healthcare sector

High & Low

All-time High

$27.85 M
ORGO quarterly cash flow from operations is currently -60.73% below its historical high of $27.85 million

3-Year Low

-$10.16 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ORGO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORGO next earnings announcement is scheduled for May 9, 2025

OtherORGOcash flowmetrics:

Quarterly CFI

-$3.36 M
ORGO quarterly cash flow from investing activities is -$3.36 million

Quarterly CFF

$33.65 M
ORGO quarterly cash flow from financing activities is $33.65 million

Quarterly FCF

$7.58 M
ORGO quarterly free cash flow is $7.58 million

Quarterly CAPEX

$3.36 M
ORGO quarterly capital expenditures is $3.36 million

TTM CFO

$14.21 M
+$323.00 K+2.33%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-77.08%

5-Year Change

-33.76%

ORGO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.33%
ORGO TTM cash flow from operations is higher than 79.33% of companies in Healthcare sector

High & Low

All-time High

$67.25 M
ORGO TTM cash flow from operations is currently -78.87% below its historical high of $67.25 million

3-Year Low

$13.88 M
ORGO TTM cash flow from operations is currently +2.33% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ORGO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORGO next earnings announcement is scheduled for May 9, 2025

OtherORGOcash flowmetrics:

TTM CFI

-$10.03 M
ORGO TTM cash flow from investing activities is -$10.03 million

TTM CFF

$27.64 M
ORGO TTM cash flow from financing activities is $27.64 million

TTM FCF

$4.18 M
ORGO TTM free cash flow is $4.18 million

TTM CAPEX

$10.03 M
ORGO TTM capital expenditures is $10.03 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ORGO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-54.0%0.0%0.0%
3 y3 years-77.1%-39.1%-77.1%
5 y5 years+142.4%+941.3%-33.8%

ORGO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-77.1%at low-39.1%+207.6%-78.0%+2.3%
5 y5-year-77.1%+142.4%-60.7%+163.3%-78.9%+134.4%
alltimeall time-77.1%+123.4%-60.7%+147.6%-78.9%+121.6%

Organogenesis Holdings Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
$14.21 M(-54.0%)
$10.94 M(+25.8%)
$14.21 M(+2.3%)
Sep 2024
-
$8.70 M(+83.5%)
$13.88 M(-36.7%)
Jun 2024
-
$4.74 M(-146.6%)
$21.92 M(-15.1%)
Mar 2024
-
-$10.16 M(-195.7%)
$25.83 M(-16.4%)
Dec 2023
$30.92 M(+24.4%)
$10.61 M(-36.6%)
$30.92 M(+10.0%)
Sep 2023
-
$16.73 M(+93.5%)
$28.10 M(+67.1%)
Jun 2023
-
$8.65 M(-270.3%)
$16.82 M(-8.4%)
Mar 2023
-
-$5.08 M(-165.1%)
$18.37 M(-26.1%)
Dec 2022
$24.86 M(-59.9%)
$7.80 M(+43.0%)
$24.86 M(-29.0%)
Sep 2022
-
$5.45 M(-46.5%)
$35.01 M(-39.0%)
Jun 2022
-
$10.20 M(+622.5%)
$57.40 M(-11.3%)
Mar 2022
-
$1.41 M(-92.1%)
$64.69 M(+4.4%)
Dec 2021
$61.98 M(+1033.9%)
$17.95 M(-35.6%)
$61.98 M(-7.8%)
Sep 2021
-
$27.85 M(+59.3%)
$67.25 M(+39.3%)
Jun 2021
-
$17.48 M(-1444.6%)
$48.26 M(+125.0%)
Mar 2021
-
-$1.30 M(-105.6%)
$21.45 M(+292.4%)
Dec 2020
$5.47 M
$23.21 M(+161.8%)
$5.47 M(-122.6%)
Sep 2020
-
$8.87 M(-195.0%)
-$24.15 M(-37.2%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$9.34 M(-46.0%)
-$38.47 M(-6.7%)
Mar 2020
-
-$17.28 M(+170.0%)
-$41.25 M(+23.0%)
Dec 2019
-$33.53 M(-44.7%)
-$6.40 M(+17.4%)
-$33.53 M(-24.7%)
Sep 2019
-
-$5.45 M(-55.0%)
-$44.53 M(-28.3%)
Jun 2019
-
-$12.12 M(+26.8%)
-$62.07 M(-5.6%)
Mar 2019
-
-$9.56 M(-45.1%)
-$65.74 M(+8.4%)
Dec 2018
-$60.63 M(+1635.9%)
-$17.41 M(-24.3%)
-$60.63 M(+31.2%)
Sep 2018
-
-$22.99 M(+45.7%)
-$46.23 M(+97.5%)
Jun 2018
-
-$15.78 M(+254.1%)
-$23.40 M(+199.2%)
Mar 2018
-
-$4.46 M(+48.7%)
-$7.82 M(+124.0%)
Dec 2017
-$3.49 M(-28.3%)
-$3.00 M(+1677.2%)
-$3.49 M(-34.6%)
Sep 2017
-
-$168.70 K(-15.5%)
-$5.34 M(+2.8%)
Jun 2017
-
-$199.70 K(+58.1%)
-$5.20 M(+4.0%)
Mar 2017
-
-$126.30 K(-97.4%)
-$5.00 M(+2.6%)
Dec 2016
-$4.87 M
-$4.85 M(>+9900.0%)
-$4.87 M(>+9900.0%)
Sep 2016
-
-$24.50 K(<-9900.0%)
-$24.50 K(<-9900.0%)
Jun 2016
-
$200.00(-200.0%)
$0.00(-100.0%)
Mar 2016
-
-$200.00
-$200.00

FAQ

  • What is Organogenesis Holdings annual cash flow from operations?
  • What is the all time high annual CFO for Organogenesis Holdings?
  • What is Organogenesis Holdings annual CFO year-on-year change?
  • What is Organogenesis Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Organogenesis Holdings?
  • What is Organogenesis Holdings quarterly CFO year-on-year change?
  • What is Organogenesis Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for Organogenesis Holdings?
  • What is Organogenesis Holdings TTM CFO year-on-year change?

What is Organogenesis Holdings annual cash flow from operations?

The current annual CFO of ORGO is $14.21 M

What is the all time high annual CFO for Organogenesis Holdings?

Organogenesis Holdings all-time high annual cash flow from operations is $61.98 M

What is Organogenesis Holdings annual CFO year-on-year change?

Over the past year, ORGO annual cash flow from operations has changed by -$16.71 M (-54.04%)

What is Organogenesis Holdings quarterly cash flow from operations?

The current quarterly CFO of ORGO is $10.94 M

What is the all time high quarterly CFO for Organogenesis Holdings?

Organogenesis Holdings all-time high quarterly cash flow from operations is $27.85 M

What is Organogenesis Holdings quarterly CFO year-on-year change?

Over the past year, ORGO quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Organogenesis Holdings TTM cash flow from operations?

The current TTM CFO of ORGO is $14.21 M

What is the all time high TTM CFO for Organogenesis Holdings?

Organogenesis Holdings all-time high TTM cash flow from operations is $67.25 M

What is Organogenesis Holdings TTM CFO year-on-year change?

Over the past year, ORGO TTM cash flow from operations has changed by $0.00 (0.00%)